We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$268B
AUM Growth
+$39.7B
Cap. Flow
+$21.8B
Cap. Flow %
8.14%
Top 10 Hldgs %
12.83%
Holding
12,049
New
1,180
Increased
5,215
Reduced
3,564
Closed
1,371

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$850M
2
AAPL icon
Apple
AAPL
+$778M
3
TSLA icon
Tesla
TSLA
+$569M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$351M
5
JNJ icon
Johnson & Johnson
JNJ
+$336M

Sector Composition

Rank Sector Weight
1 Technology 10.83%
2 Healthcare 7.49%
3 Financials 7.15%
4 Consumer Discretionary 4.92%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EYPT icon
9601
EyePoint Inc
EYPT
$1.01B
$2.45K ﹤0.01%
700
+100
+17% +$441
BPTS
9602
DELISTED
Biophytis SA American Depositary Share (0.01 Euro)
BPTS
$2.44K ﹤0.01%
15
-23
-61% -$4.54K
GFAI icon
9603
Guardforce AI
GFAI
$10.2M
$2.43K ﹤0.01%
468
-1,574
-77% -$12.4K
PASG icon
9604
Passage Bio
PASG
$15.1M
$2.43K ﹤0.01%
88
-504
-85% -$12.7K
TWIN icon
9605
Twin Disc
TWIN
$348M
$2.43K ﹤0.01%
250
-1,070
-81% -$11.3K
GET
9606
DELISTED
Getnet Adquirencia e Servicos para Meios de Pagamento S.A. American Depositary Shares
GET
$2.42K ﹤0.01%
+1,426
New +$2.54K
VLN.WS
9607
DELISTED
Valens Semiconductor Ltd Warrants
VLN.WS
$2.42K ﹤0.01%
+5,895
New +$1.66K
GDC icon
9608
GD Culture Group
GDC
$7.2M
$2.4K ﹤0.01%
+5
New +$4.51K
GMBLP
9609
DELISTED
Esports Entertainment Group Inc. 10.0% Series A Cumulative Redeemable Convertible Preferred Stock
GMBLP
$2.39K ﹤0.01%
922
-4,009
-81% -$13K
PPHPU
9610
DELISTED
PHP Ventures Acquisition Corp. Units
PPHPU
$2.39K ﹤0.01%
237
RBOT.WS
9611
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
$2.38K ﹤0.01%
+15,842
New +$5.89K
IMMP
9612
Immutep
IMMP
$58.2M
$2.37K ﹤0.01%
1,353
-9,232
-87% -$18.3K
QED
9613
DELISTED
IQ Hedge Event-Driven Tracker ETF
QED
$2.37K ﹤0.01%
117
-794
-87% -$16.5K
RNERU
9614
DELISTED
Mount Rainier Acquisition Corp. Unit
RNERU
$2.36K ﹤0.01%
197
CHIM
9615
DELISTED
Global X MSCI China Materials ETF
CHIM
$2.35K ﹤0.01%
134
-682
-84% -$11.7K
AMOM icon
9616
Qraft AI-Enhanced US Large Cap Momentum ETF
AMOM
$25M
$2.34K ﹤0.01%
89
-1,961
-96% -$52.1K
BACK
9617
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
$2.34K ﹤0.01%
390
+358
+1,119% +$3.46K
CSLM
9618
DELISTED
CSLM Acquisition Corp. Class A Ordinary Share
CSLM
$2.33K ﹤0.01%
230
-50
-18% -$501
MESO
9619
Mesoblast
MESO
$1.94B
$2.33K ﹤0.01%
400
-1,760
-81% -$11K
EUDA icon
9620
EUDA Health Holdings
EUDA
$49.4M
$2.32K ﹤0.01%
70
+7
+11% +$818
FEED
9621
ENvue Medical Inc
FEED
$2.25M
$2.31K ﹤0.01%
4
-9
-69% -$7.41K
NPCE icon
9622
Neuropace
NPCE
$458M
$2.31K ﹤0.01%
1,552
-621
-29% -$1.38K
BNIX
9623
DELISTED
Bannix Acquisition Corp. Common Stock
BNIX
$2.31K ﹤0.01%
227
-1,210
-84% -$12.2K
TOVX icon
9624
Theriva Biologics
TOVX
$10.4M
$2.31K ﹤0.01%
201
-70
-26% -$1.27K
WEL.U
9625
DELISTED
Integrated Wellness Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
WEL.U
$2.3K ﹤0.01%
224

Similar funds

UBS Group's Q4 2022 Portfolio in Review

As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,215 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.

  • UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
  • UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
  • UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
  • UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
  • UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
  • UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
  • UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.